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CLINICAL SCENARIO
You are asked to see in your clinic a 49-year-old man with
a two-day history of left-sided upper chest pain, which
radiates to the jaw and is associated with mild shortness of
breath. The pain occurred at rest, was rated as 8/10 in
intensity, and lasted for approximately 1 h. The pain
recurred the following day and lasted for 30 min. He is
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pain-free at the time of his clinic visit. The patient took
aspirin without relief; he did not have access to nitroglyc-
erin. Past medical history is significant for hypertension,
controlled on hydrochlorothiazide. Cholesterol is unknown.
He has no history of coronary artery disease or other
vascular disease. He smokes two packs of cigarettes per day
(66 pack years). After a normal physical examination,
electrocardiogram (ECG) was obtained and showed normal
sinus rhythm (rate 78) with 0.5 mm of ST elevation in leads
III and aVF. No prior ECG was available for comparison.
Chest X-ray was negative for infiltrates, effusion, or pneu-
mothorax.
You suspect that the patient has unstable angina and
decide to admit the patient to a monitored bed to rule out
myocardial infarction (MI). The patient minimizes his
recent symptoms and asks for an explanation of the necessity
for immediate hospitalization. You have seen various clini-
cal prediction rules and guidelines for patients with symp-
toms of unstable angina in the medical literature, and you
refer to these sources to better characterize the patient’s
short-term risk of adverse outcomes, including nonfatal MI
and death.
DISCUSSION
Prior efforts to stratify patients presenting with symptoms
suspicious for an acute coronary syndrome (ACS), including
unstable angina and MI, have concentrated upon the
identification of high-risk clinical indicators and electrocar-
diographic (ECG) findings (1,2). Other attempts to im-
prove the appropriateness of the triage of patients with
suspected ACS have included the use of rapid determina-
tion of cardiac enzymes (3,4), cardiac troponin (5–7),
two-dimensional echocardiography (8,9), thallium-201
scintigraphy (10), and Tc99m-sestamibi single-photon
emission computed tomography (SPECT) scanning
(11,12). Several of these methods have significant limita-
tions, however.
Although serial cardiac enzymes show excellent sensitiv-
ity in the detection of acute MI, use of a single measurement
to guide triage at the time of initial evaluation generally does
not (except in the case where ischemic symptoms have been
prolonged for at least 8 to 10 h) (13). Elevated troponin
levels have been demonstrated to identify patients with
unstable angina at increased risk of adverse cardiovascular
events during follow-up (14–17); however, optimal triage
and initial management of the large number of patients with
marginally elevated (or indeterminate) troponin values re-
mains uncertain, which argues against the indiscriminate
use of this test in all patients with symptoms of possible
ACS (18). The routine use of echocardiography and radio-
nuclide imaging in the emergency department (ED) detec-
tion of ACS, while promising, depends upon the ready,
around-the-clock availability of technical staff, expensive
equipment, and/or radioisotopes, which is problematic at
the majority of facilities without these resources. Both of
these techniques may yield normal results in patients with
small infarctions or small areas of at-risk myocardium
(reducing sensitivity), and may present difficulties in differ-
entiating between acute ischemia and old infarction in the
ED (reducing specificity).
Related work has suggested the potential utility of critical
pathways, accelerated diagnostic protocols, and chest pain
observation units in reducing hospitalization for patients
with possible unstable angina who are determined to be at
low risk for acute cardiac complications (19–21). Indeed,
the effective use of these strategies depends on the ability to
recognize patients with possible ACS and to estimate the
pretest probability of short-term adverse outcomes. For this
purpose, risk stratification models, which are based on a
combination of clinical and ECG findings, can be applied to
predict short-term outcome in patients with unstable angina
(22,23), and more generally in patients with symptoms
suggestive of ACS (24–27).
In this issue of the Journal, Calvin et al. (28) present
evidence to support the validity of a previously reported
model originally developed to determine which factors of
the Braunwald classification of unstable angina (29) predict
the occurrence of in-hospital cardiac complications (22,30).
In an analysis of 416 consecutively admitted patients diag-
nosed with unstable angina, the investigators compared the
performance of two risk stratification models for unstable
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angina: 1) the modified Braunwald (RUSH) model, and 2)
the Agency for Healthcare Research and Quality (AHRQ)
risk model. Based on the RUSH model, predicted proba-
bilities of complications were grouped into three categories:
a priori low (,5%), intermediate (5% to 25%), and high risk
(.25%). The difference in observed complications among
risk groups was statistically significant when recurrent an-
gina with ST depression, a secondary end point, was
included in the composite outcome (4%, 9%, and 19% for
low, intermediate, and high-risk groups, respectively).
Agreement between observed and predicted complication
rates was good at the low range of the probability scale (0%
to 15%), but was poor at higher values. Possible explana-
tions for this discrepancy are: 1) that the model was used to
predict somewhat different outcomes compared to those
examined in the original study (31) [In the original predic-
tive model, major in-hospital cardiac complications were
defined by the occurrence of death, MI after the first 24 h,
congestive heart failure, ventricular tachycardia, or ventric-
ular fibrillation. Recurrent ischemia with ST depression was
not included in this definition]; 2) that the AHRQ
guideline-based reminders, which were posted on each chart
during the study period (32), may have resulted in improved
care for high-risk patients. In this regard, the article by
Calvin et al. (Table 3) indicates that patients at increased
risk according to the RUSH model were more likely to
receive IV nitroglycerin (with a trend toward increased use
of IV heparin and surgery in these patients). More aggres-
sive therapy may have lowered the observed rate of cardiac
events (such as recurrent ischemia) for patients predicted to
be at high risk.
The AHRQ guideline identified a smaller fraction of
low-risk patients eligible for possible outpatient workup and
performed less favorably in discriminating between patients
at low versus intermediate to high risk of in-hospital cardiac
complications. Indeed, the small fraction of patients iden-
tified as low risk by the AHRQ risk model has raised doubts
regarding the clinical applicability of this model in patients
with suspected unstable angina (33). Previous work, how-
ever, suggests that the AHRQ risk model does effectively
identify patients at low risk of adverse outcomes over the
short and long term (34–36). The unexpected results in the
study by Calvin et al. may be attributable in part to selection
factors.
First, the inclusion criteria limited the study sample to
inpatients with several intermediate-high risk features of
unstable angina. Second, use of the AHRQ guideline by
emergency physicians in the initial evaluation of patients
with suspected unstable angina may have affected triage
decisions, leading to the ED discharge of patients classified
as low risk according to the guideline; unfortunately, no
information on whether the guideline was implemented in
the ED is reported. Both of these factors would tend to
reduce the proportion of guideline-identified low-risk pa-
tients in the study sample and to attenuate differences
between guideline risk groups.
How do the two models compare in guiding the initial
risk assessment of the patient in the above clinical scenario?
Based on the RUSH model, our patient has a predicted
probability of in-hospital cardiac complications of 6% (in
the intermediate-risk range), given his age and history of
not having received a beta-blocker (none of the other
variables in the model apply). In contrast, the AHRQ risk
model would also assign this patient to the intermediate-
risk group (average observed risk of in-hospital complica-
tions, 9%), based on his history of prolonged rest angina
(.20 min), which had resolved by the time of presentation.
Although the two risk models include several common
prognostic factors that are associated with cardiac compli-
cations in the literature, the AHRQ risk model captures
additional clinical and ECG factors that are useful for risk
stratification not only in patients with presumed unstable
angina but also in the more heterogeneous spectrum of
patients with symptoms suggestive of ACS. The perfor-
mance of both models in a less selected population of
patients presenting with symptoms suggestive of ACS in the
ED, either alone or as part of a strategy including cardiac
enzymes, exercise testing, and/or imaging, warrants further
evaluation.
The risk model by Calvin et al. adds to a growing
armamentarium of prediction rules that can help clinicians
initially estimate the probability of short-term adverse
outcomes in patients with suspected unstable angina. In
addition, the investigators have performed a valuable service
by raising new questions about a widely disseminated
national guideline for unstable angina and the importance of
confirming the validity of this and similar guidelines in
target clinical settings. Few of these decision aids in isola-
tion have been shown prospectively in large controlled trials
to reduce the number of unnecessary critical care unit
admissions for patients without ACS or to decrease the rate
of inappropriate discharge of patients with confirmed ACS
(37,38); even fewer have demonstrated the impact of im-
plementing predictive models on clinical outcome.
Nonetheless, these tools have an emerging role at the
“front-end” of clinical strategies for the initial triage and
management of these patients, and they can anchor deci-
sions regarding the need for additional observation in a
chest-pain center, the use of accelerated protocols or cardiac
imaging, and/or the administration of intensive medical
treatment (heparin, antiplatelet agents, early revasculariza-
tion). Clinicians should take advantage of validated risk
stratification models and other decision aids in patients with
suspected ACS, and they should use additional tests/
procedures as indicated to revise initial estimates of the
probability of adverse cardiac events.
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